CG From the
-
Moving Beyond AAV: The Next Generation Of Vectors In CGT
12/11/2023
We catch up with Dr. Konstantin Konstantinov, CTO at Ring Therapeutics, and Ryan Crisman, Ph.D., cofounder and CTO at Umoja Biopharma, to get their thoughts on the future of new anellovirus vectors and existing lentiviral vector technology for in vivo gene delivery respectively.
-
Preparing Your CAR-T Therapy For Phase 2 Trials
12/6/2023
AffyImmune CEO, Matt Britz, talks about what’s next for the company as it prepares its lead CAR-T candidate for Phase 2 trials — from clinical strategy to selecting a CDMO and the headache of tech transfers.
-
Video Clips From Cell & Gene Live: Optimizing Your Cold Chain For Cell Therapies
11/30/2023
For your convenience, we’ve broken down our Cell & Gene Live, Optimizing Your Cold Chain for Cell Therapies, into bite-size video clips by topic.
-
A Sneak Peek At Providence Therapeutics On Cell & Gene: The Podcast
11/29/2023
On an upcoming episode of Cell & Gene: The Podcast, I talk to Robert Georgantas III, Ph.D., of Providence Therapeutics, about their mRNA vaccine therapies. Here's a preview of our conversation.
-
Vor Bio Shares Progress For Patients with AML
11/17/2023
I talked to Dr. Robert Ang, President and Chief Executive Officer at Vor Bio about the company's VBP101 study for trem-cel in patients with acute myeloid leukemia (AML)
-
The Eye: A Candidate For Modifier Gene Therapy
11/17/2023
Ocugen's Chairman, CEO and Co-founder, Shankar Musunuri ,Ph.D., MBA, provides an update on OCU400 and other ongoing trials, why the eye is a good target for gene therapy, the outlook for retinal gene therapy, and more.
-
How Creative Licensing Can Improve Patient Access
11/16/2023
Members of Caring Cross and UC Berkeley's Innovative Genomics Institute and Office of IP And Industry Research Alliances discuss the important role technology transfer offices (TTOs) play in improving ATMP accessibility. TTOs can accomplish this by designing "strings-attached" research and licensing deals upstream in product development.
-
Important Ethical Questions Concerning CGTs
11/3/2023
This is a summary of Alliance For Regenerative Medicine's panel discussion, "The Importance Of Ethics In Gene And Cell Therapy," from this year's Meeting On The Mesa.
-
Video Clips From Cell & Gene Live: Regulating The CGT Workflow To Improve Patient Safety
10/31/2023
Here is a breakdown of original 60-minute Cell & Gene Live, Regulating the CGT Workflow to Improve Patient Safety, into video segments by topic.
-
Legal And IP Protection For New Biotechs
10/31/2023
Want to ensure you've got your biotech legal, IP, and patent bases covered? Join Business of Biotech host Matt Pillar and BlueSphere Bio CEO and biotech legal expert Keir LoIacono on 11/13 for the live, interactive, and FREE digital event Legal And IP Protection For New Biotechs.